Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model ; volume:12 ; number:1 ; day:9 ; month:11 ; year:2012 ; pages:1-12 ; date:12.2012
BMC health services research ; 12, Heft 1 (9.11.2012), 1-12, 12.2012
- Creator
-
Bakır, Mustafa
- Contributor
-
Türel, Özden
Topachevskyi, Oleksandr
SpringerLink (Online service)
- DOI
-
10.1186/1472-6963-12-386
- URN
-
urn:nbn:de:1111-2016072140692
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bakır, Mustafa
- Türel, Özden
- Topachevskyi, Oleksandr
- SpringerLink (Online service)
Other Objects (12)
Strengths and weaknesses of pneumococcal conjugate vaccines
Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
Conjugate vaccines
Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children
Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults
Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment
Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis
Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools
Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Higher-valency pneumococcal conjugate vaccines in older adults, taking into account indirect effects from childhood vaccination: a cost-effectiveness study for the Netherlands
13-Valent pneumococcal conjugate vaccines vaccination innovative strategy in Weifang City, China: a case study
Strengths and weaknesses of pneumococcal conjugate vaccines
Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
Conjugate vaccines
Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children
Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults
Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment
Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis
Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools
Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Higher-valency pneumococcal conjugate vaccines in older adults, taking into account indirect effects from childhood vaccination: a cost-effectiveness study for the Netherlands
13-Valent pneumococcal conjugate vaccines vaccination innovative strategy in Weifang City, China: a case study
Strengths and weaknesses of pneumococcal conjugate vaccines
Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
Conjugate vaccines
Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children
Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults
Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment
Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis
Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools
Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Higher-valency pneumococcal conjugate vaccines in older adults, taking into account indirect effects from childhood vaccination: a cost-effectiveness study for the Netherlands